Mayur Yc (Y C Mayur)

Years Active: 2019-2023
Publications (10 Years): 6

Universal Remedies

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Universal Remedies Aug 01 1993 - Aug 31 1995

India

Production Supervisor :: Oral Dosage Production

Publications

Tanuja T Yadav, Piyush D Patil, Gulam Moin Shaikh, Maushmi S Kumar, Meena Chintamaneni, Mayur Yc
Evaluation of N 10 -substituted acridone-based derivatives as AKT inhibitors against breast cancer cells: in vitro and molecular docking studies. 3 Biotech 13 (4) (2023)
Tanuja T Yadav, Maushmi Shailesh Kumar, Shalini Bajaj, Mayur Yc
Design, synthesis and evaluation of acridone-2-carbohydrazide derivatives as p-AKT Ser 473 kinase inhibitors. Future medicinal chemistry 15 (8) (2023)
Tanuja T Yadav, Piyush D Patil, Gulam Moin Shaikh, Maushmi S Kumar, Meena Chintamaneni, Mayur Yc
Evaluation of N 10 -substituted acridone-based derivatives as AKT inhibitors against breast cancer cells: in vitro and molecular docking studies. 3 Biotech 13 (4) (2023)
Tanuja T Yadav, Maushmi Shailesh Kumar, Shalini Bajaj, Mayur Yc
Design, synthesis and evaluation of acridone-2-carbohydrazide derivatives as p-AKT Ser 473 kinase inhibitors. Future medicinal chemistry (2023)
Tanuja T Yadav, Maushmi Shailesh Kumar, Shalini Bajaj, Mayur Yc
Design, synthesis and evaluation of acridone-2-carbohydrazide derivatives as p-AKT Ser 473 kinase inhibitors. Future medicinal chemistry 15 (8) (2023)
Mrunal J Sharma, Maushmi S Kumar, Manikanta Murahari, Mayur Yc
Synthesis of novel gefitinib-based derivatives and their anticancer activity. Archiv der Pharmazie 352 (5) (2019)

Mayur Yc.css-eqlu8i{font-size:small;padding-left:4px;} (Y C Mayur)